Pediatric Primary Care Case Studies (138 page)

American Academy of Pediatric Dentistry,
409
,
412
–413

American Academy of Pediatrics.
See
AAP (American Academy of Pediatrics)

American Cancer Society.
See
ACS (American Cancer Society)

American Community Survey,
225

American Diabetes Association,
269
–271,
271
t,
278

amoxicillin,
353
,
355
t,
423
,
472
–473

amoxicillin/clavulanate (Augmentin),
355
t

ampicillin,
472
–473

anemia (toddlers),
291
–320

case presentation for,
291
–295,
315
–316

diagnosis,
296
–309

anemia as symptom,
301
–303

anemia phases,
300
–302

diagnostic testing,
308
–313,
310
t–312t

differential,
296

environmental toxins,
296
–299,
298
t–299t

history-taking,
292
–293

hypothyroidism,
306
–307,
309

I PREPARE mnemonic,
298
–299,
299
t

ICD-9 codes,
313
t

IDA,
300
–303,
300
t,
308

lead poisoning,
303
–305,
309

leukemia,
305
–306

lymphoma,
305
–306

pathophysiology,
299
–301

physical examinations,
294
–296,
295
t

systems reviews,
293
–295

warfarin toxicity,
306
,
308

epidemiology/etiology of,
296

fundamental contexts of,
291
,
317

management of,
313
–327

care plans,
315
–316

follow-up visits,
316
–317

medications,
314
–315

objectives for,
291

resources for,
317
–320

angiotensin-converting enzyme inhibitors.
See
ACE (angiotensin-converting enzyme) inhibitors

antibiotics

oral,
353
–354,
353
t,
399
,
421
,
462
–463,
472
–473

topical,
472

antidepressants,
215
–219,
217
t

antidepressants, tricyclic,
218

antihistamines,
68
,
343
t

antihistamines/mast cell stabilizers,
343
t

antihistamines/vasoconstrictors,
343
t

antipyrine/benzocaine (Auralgan),
356
t

antivirals,
463

appendicitis,
395
–396

Applied Behavior Analysis program.
See
ABA (Applied Behavior Analysis) program

Aquaphor,
460

AS (Asperger syndrome),
28

ASDs (autistic spectrum disorders),
28
–40,
29
t,
30
f.
See also
language/social delays (toddlers)

Atopic dermatitis.
See
AD (atopic dermatitis)

Atopiclair,
463

Attention deficit hyperactivity disorder.
See
ADHD (attention deficit hyperactivity disorder)

Augmentin.
See
amoxicillin/clavulanate (Augmentin)

Auralgan.
See
antipyrine/benzocaine (Auralgan)

Autism and Developmental Disabilities Monitoring Network,
29

autistic spectrum disorders.
See
ASDs (autistic spectrum disorders)

autoimmune hepatitis,
472
–473

Aveeno soap,
460

Avita.
See
tretinoin (Retin-A, Avita)

avoidance, healthcare,
223
–224

avulsion.
See also
oral trauma

permanent incisors,
405
–414,
409
f

primary incisors,
405
–414,
408
f

AWHONN (Association of Women’s Health, Obstetric and Neonatal Nurses),
503

azathioprine,
462

azelastine HCl (Optivar),
343
t

azithromycin,
353
–354,
353
t,
355
t,
383
–384

B

bacturia,
418
–419

barrier method/spermicides,
433

benzocaine/antipyrine (Auralgan),
356
t

benzoyl peroxide,
472
,
474
t–477t

best evidence
vs
. best practice,
1
–5,
372
–374

Biaxin.
See
clarithromycin (Biaxin)

biguanides,
278

birth control (adolescents),
427
–440

case presentation for,
427
–428,
434
,
437
–439

diagnosis of,
428
–430

diagnostic testing,
428

history-taking,
429
–430

physical examination,
428

fundamental contexts of,
427
,
439

management of,
430
–439

COC pills,
435
b–437b

contraceptive options,
430
–434,
431
t

counseling,
437
–438

follow-up visits,
438
–439

objectives for,
427

resources for,
439
–440

bisexual issues.
See
LGBT (lesbian, gay, bisexual, and transgendered) issues

blood glucose diaries,
268
t

BMI (body mass index),
89
–90

Bogalusa Heart Study,
272
–273

Bordetella pertussis
,
379
t

BRAT (bananas, rice, applesauce, toast) diet,
399

breastfeeding/slow weight gain (infants),
103
–114

case presentation for,
103
–111

diagnosis of,
108
–109

first visit,
104
–108

breastfeeding observations,
108

history-taking,
105
–107

maternal
vs
. infant problems,
105
t–107t

physical examination,
107

fundamental contexts of,
103
,
111

management of,
109
–111

AAP recommendations,
104

follow-up visits,
109
–111

guidelines,
104
,
104
t,
112
t